Caroline Dorsa has an estimated net worth of $31.6 Million. This is based on reported shares across multiple companies, which include BIOGEN INC., Duke Energy CORP, GILEAD SCIENCES INC, ILLUMINA, INC., Goldman Sachs Real Estate Diversified Income Fund, Goldman Sachs Credit Income Fund, Goldman Sachs MLP Income Opportunities Fund, Goldman Sachs Private Markets Fund 2018 (B) LLC, Goldman Sachs Private Markets Fund 2018 (A) LLC, Goldman Sachs Private Markets Fund 2018 LLC, Intellia Therapeutics, Inc., GOLDMAN SACHS MLP & ENERGY RENAISSANCE FUND, MERCK & CO INC, AVAYA INC, and PUBLIC SERVICE ENTERPRISE GROUP INC.

2010 was Caroline Dorsa's most active year for acquiring shares with 16 total transactions. Caroline Dorsa's most active month to acquire stocks was the month of April. 2015 was Caroline Dorsa's most active year for disposing of shares, totalling 63 transactions. Caroline Dorsa's most active month to dispose stocks was the month of July. 2006 saw Caroline Dorsa paying a total of $2,045,936.29 for 129,771.356 shares, this is the most they've acquired in one year. In 2016 Caroline Dorsa cashed out on 55,140 shares for a total of $8,656,980.00, their largest year based on trade value.